67 related articles for article (PubMed ID: 17418218)
1. Can long-term antibiotic treatment prevent progression of peripheral arterial occlusive disease? A large, randomized, double-blinded, placebo-controlled trial.
Joensen JB; Juul S; Henneberg E; Thomsen G; Ostergaard L; Lindholt JS
Atherosclerosis; 2008 Feb; 196(2):937-42. PubMed ID: 17418218
[TBL] [Abstract][Full Text] [Related]
2. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
[TBL] [Abstract][Full Text] [Related]
3. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.
Wiesli P; Czerwenka W; Meniconi A; Maly FE; Hoffmann U; Vetter W; Schulthess G
Circulation; 2002 Jun; 105(22):2646-52. PubMed ID: 12045171
[TBL] [Abstract][Full Text] [Related]
4. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
[TBL] [Abstract][Full Text] [Related]
5. Progression of peripheral arterial occlusive disease is associated with Chlamydia pneumoniae seropositivity and can be inhibited by antibiotic treatment.
Krayenbuehl PA; Wiesli P; Maly FE; Vetter W; Schulthess G
Atherosclerosis; 2005 Mar; 179(1):103-10. PubMed ID: 15721015
[TBL] [Abstract][Full Text] [Related]
6. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
; Leizorovicz A; Becker F
Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
[TBL] [Abstract][Full Text] [Related]
7. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
[TBL] [Abstract][Full Text] [Related]
8. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).
Hiatt WR; Money SR; Brass EP
J Vasc Surg; 2008 Feb; 47(2):330-336. PubMed ID: 18155871
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
Cannon CP; Braunwald E; McCabe CH; Grayston JT; Muhlestein B; Giugliano RP; Cairns R; Skene AM;
N Engl J Med; 2005 Apr; 352(16):1646-54. PubMed ID: 15843667
[TBL] [Abstract][Full Text] [Related]
11. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease.
O'Donnell ME; Badger SA; Sharif MA; Young IS; Lee B; Soong CV
J Vasc Surg; 2009 May; 49(5):1226-34. PubMed ID: 19217745
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
14. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.
Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
Circulation; 2004 Mar; 109(8):1010-5. PubMed ID: 14769704
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
[TBL] [Abstract][Full Text] [Related]
16. Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50.
Bonaca MP; Scirica BM; Creager MA; Olin J; Bounameaux H; Dellborg M; Lamp JM; Murphy SA; Braunwald E; Morrow DA
Circulation; 2013 Apr; 127(14):1522-9, 1529e1-6. PubMed ID: 23501976
[TBL] [Abstract][Full Text] [Related]
17. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
[TBL] [Abstract][Full Text] [Related]
18. Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events.
Berg HF; Maraha B; Scheffer GJ; Quarles-van Ufford M; Vandenbroucke-Grauls CM; Peeters MF; Kluytmans JA
Clin Infect Dis; 2005 Feb; 40(3):358-65. PubMed ID: 15668857
[TBL] [Abstract][Full Text] [Related]
19. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
Black PN; Blasi F; Jenkins CR; Scicchitano R; Mills GD; Rubinfeld AR; Ruffin RE; Mullins PR; Dangain J; Cooper BC; David DB; Allegra L
Am J Respir Crit Care Med; 2001 Aug; 164(4):536-41. PubMed ID: 11520711
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic therapy after acute myocardial infarction: a prospective randomized study.
Zahn R; Schneider S; Frilling B; Seidl K; Tebbe U; Weber M; Gottwik M; Altmann E; Seidel F; Rox J; Höffler U; Neuhaus KL; Senges J;
Circulation; 2003 Mar; 107(9):1253-9. PubMed ID: 12628944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
